Fiji vs Timor-Leste: HIV/AIDS deaths averted by antiretroviral therapy
Fiji
82.71 deaths
in 2024
Timor-Leste
93.18 deaths
in 2024
Fiji rank
128th
Timor-Leste rank
126th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Fiji
- Timor-Leste
How they compare
Timor-Leste currently reports 93.18 deaths against 82.71 deaths in Fiji, a difference of 10.47 deaths.
That makes Timor-Leste's figure about 1.1 times Fiji's.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Timor-Leste ahead.
Fiji ranks 128th and Timor-Leste ranks 126th of 157 countries.
Timor-Leste has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Fiji | Timor-Leste | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 0.4499 deaths | 1.78 deaths | 1.33 deaths | Timor-Leste |
| 2010s | 13.52 deaths | 23.13 deaths | 9.61 deaths | Timor-Leste |
| 2020s | 53.81 deaths | 74.8 deaths | 20.99 deaths | Timor-Leste |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Fiji or Timor-Leste?
- Timor-Leste, at 93.18 deaths against 82.71 deaths in Fiji as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Fiji and Timor-Leste?
- 10.47 deaths, with Timor-Leste ahead.
- How many years of comparable data are there for Fiji and Timor-Leste?
- 35 years are reported by both, from 1990 to 2024.
- How do Fiji and Timor-Leste rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Fiji ranks 128th and Timor-Leste ranks 126th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.